Sartorius transposition during inguinal lymphadenectomy for melanoma

Journal of Surgical Research

Volumn 184, Issue 1, 2013, Pages 209-215

  Bartlett, Edmund K ^a   Meise, Chelsey ^a   Bansal, Neha ^a   Fischer, John P ^a   Low, David W ^a   Czerniecki, Brian J ^a   Roses, Robert E ^a   Fraker, Douglas L ^a   Kelz, Rachel R ^a   Karakousis, Giorgos C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Inguinal lymph node dissection; Melanoma; Sartorius transposition flap; Wound complication

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; BODY MASS; COMORBIDITY; DEATH; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INGUINAL LYMPHADENECTOMY; LUNG EMBOLISM; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MELANOMA; OPERATING ROOM; OPERATION DURATION; PNEUMONIA; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK FACTOR; SARTORIUS TRANSPOSITION; SKIN INFECTION; SMOKING; SURGICAL INFECTION; SURGICAL TECHNIQUE; URINARY TRACT INFECTION; WOUND COMPLICATION; WOUND DEHISCENCE;

EID: 84884672516     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.04.033     Document Type: Article

References (33)

1. DesmondRA,Soong SJ. Epidemiology of malignantmelanoma. Surg Clin North Am 2003;83:1.
2. Howlader N NA, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA SEER Cancer Statistics Review, 1975e2009 National Cancer Institute. Bethesda, MD 2011.
3. Harlan LC, Lynch CF, Ballard-Barbash R, Zeruto C. Trends in the treatment and survival for local and regional cutaneous melanoma in a US population-based study. Melanoma Res 2011;21:547.
4. Gershenwald JE, Thompson W, Mansfield PF, et al. Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976.
5. Karakousis GC, Gimotty PA, Czerniecki BJ, et al. Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients. Ann Surg Oncol 2007; 14:1596.
6. Cho E, Rosner BA, Colditz GA. Risk factors for melanoma by body site. Cancer Epidemiol Biomarkers Prev 2005;14:1241.
7. MSLT-II. Complete lymph node dissection or observation in treating patients with localized melanoma and sentinel node metastasis who have undergone sentinel lymphadenectomy (MSLT-II). Available at: http://www.clinicaltrials. gov/ct/show/NCT00389571.orderÂ?1. 2012.
8. Coit DG, Andtbacka R, Anker CJ, et al. Melanoma. J Natl Compr Canc Netw 2012;10:366.
9. Balch CM, Soong S, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000;7:87.
10. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355:1307.
11. Bilimoria KY, Balch CM, Bentrem DJ, et al. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol 2008;15:1566.
12. Beitsch P, Balch C. Operative morbidity and risk factor assessmentinmelanomapatients undergoing inguinal lymph node dissection. Am J Surg 1992;164:462. discussion 465e6.
13. Chang SB, Askew RL, Xing Y, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol 2010;17:2764.
14. Coit DG, Peters M, Brennan MF. A prospective randomized trial of perioperative cefazolin treatment in axillary and groin dissection. Arch Surg 1991;126:1366. discussion 1371e2.
15. de Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol 2006;32:785.
16. Hughes TM, Aa™Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 2000;87:892.
17. Karakousis CP, Driscoll DL, Rose B, Walsh DL. Groin dissection in malignant melanoma. Ann Surg Oncol 1994;1:271.
18. Poos HP, Kruijff S, Bastiaannet E, et al. Therapeutic groin dissection for melanoma: risk factors for short term morbidity. Eur J Surg Oncol 2009;35:877.
19. Sabel MS, Griffith KA, Arora A, et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery 2007;141:728.
20. Serpell JW, Carne PW, Bailey M. Radical lymph node dissection for melanoma. ANZ J Surg 2003;73:294.
21. Wevers KP, Poos HP, van Ginkel RJ, et al. Early mobilization after ilio-inguinal lymph node dissection for melanoma does not increase the wound complication rate. Eur J Surg Oncol; 2012.
22. Baas PC, Schraffordt Koops H, Hoekstra HJ, et al. Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg 1992;127:281.
23. Tonouchi H, Ohmori Y, Kobayashi M, et al. Operative morbidity associated with groin dissections. Surg Today 2004;34:413.
24. Abbas S, Seitz M. Systematic review and meta-analysis of the used surgical techniques to reduce leg lymphedema following radical inguinal nodes dissection. Surg Oncol 2009; 20:88.
25. JudsonPL, Jonson AL, Paley PJ, et al.Aprospective, randomized study analyzing sartorius transposition following inguinalfemoral lymphadenectomy. Gynecol Oncol 2004;95:226.
26. Sarnaik AA, Puleo CA, Zager JS, Sondak VK. Limiting the morbidity of inguinal lymphadenectomy for metastatic melanoma. Cancer Control 2009;16:240.
27. Raval MV, Hamilton BH, Ingraham AM, et al. The importance of assessing both inpatient and outpatient surgical quality. Ann Surg 2011;253:611.
28. Shiloach M, Frencher SK Jr, Steeger JE, et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 2009;210:6.
29. Daley J, Forbes MG, Young GJ, et al. Validating risk-adjusted surgical outcomes: site visit assessment of process and structure. National VA Surgical Risk Study. J Am Coll Surg 1997;185:341.
30. User Guide for the 2010 Participant Use Data File. Americal College of Surgeons National Surgical Quality Improvement Program 2011; http://site.acsnsqip.org/wp-content/uploads/2012/03/2010-User-Guide-FINAL.pdf.
31. Juul S. F, M. An Introduction to Stata for Health Researchers. 3rd Ed. StataCorp LP 2010:pp.179e196.
32. Finan KR, Vick CC, Kiefe CI, et al. Predictors of wound infection in ventral hernia repair. Am J Surg 2005;190:676.
33. Fowler VG Jr, Oa™Brien SM, Muhlbaier LH, et al. Clinical predictors of major infections after cardiac surgery. Circulation 2005;112(9 Suppl):I358.